Pharmacokinetic and Metabolic Studies of ADTM: A Novel Danshensu Derivative Confers Cardioprotection by HPLC-UV and LC-MS/MS

Journal of Chromatographic Science

Volumn 53, Issue 6, 2015, Pages 872-878

  Li, Sai ^a,b   Shan, Luchen ^a   Zhang, Zaijun ^a   Li, Wei ^a   Liao, Kaiyi ^a   Li, Sha ^a   Sheng, Xiaoyan ^b   Yu, Pei ^a   Wang, Yuqiang ^a  

^a JINAN UNIVERSITY   (China)

^b Southern Medical University   (China)

Author keywords

[No Author keywords available]

Indexed keywords

RATTUS;

(3,5,6-TRIMETHYLPYRAZINYL)METHYL 2-ACETOXY-3-(3,4-DIACETOXYPHENYL)PROPANOATE; 3,4-DIHYDROXYPHENYLLACTIC ACID; CARDIOTONIC AGENT; LACTIC ACID DERIVATIVE; PHENYLPROPIONIC ACID DERIVATIVE; PYRAZINE DERIVATIVE;

ANIMAL; BLOOD; CHEMISTRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIMIT OF DETECTION; MALE; METABOLISM; PROCEDURES; RAT; REPRODUCIBILITY; SPRAGUE DAWLEY RAT; STATISTICAL MODEL; TANDEM MASS SPECTROMETRY;

ANIMALS; CARDIOTONIC AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; LACTATES; LIMIT OF DETECTION; LINEAR MODELS; MALE; PHENYLPROPIONATES; PYRAZINES; RATS; RATS, SPRAGUE-DAWLEY; REPRODUCIBILITY OF RESULTS; TANDEM MASS SPECTROMETRY;

EID: 84930622994     PISSN: 00219665     EISSN: None     Source Type: Journal    
DOI: 10.1093/chromsci/bmu133     Document Type: Article

References (18)

1. Cheng, T.O.; Danshen: a versatile Chinese herbal drug for the treatment of coronary heart disease; International Journal of Cardiology, (2006); 113: 437-438.
2. Cheng, T.O.; Cardiovascular effects of Danshen; International Journal of Cardiology, (2007); 121: 9-22.
3. Lin, Y.L., Lee, Y.C., Huang, C.L., Lai, W.L., Lin, Y.R., Huang, N.K.; Ligusticum chuanxiong prevents rat pheochromocytoma cells from serum deprivation-induced apoptosis through a protein kinase A-dependent pathway; Journal of Ethnopharmacology, (2007); 109: 428-434.
4. Zhou, L.M., Zuo, Z., Chow, M.S.S.; Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use; Journal of Clinical Pharmacology, (2005); 45: 1345-1359.
5. Su, Q.H.; Tasly pharmaceuticals: focusing on word of mouth marketing; Contemporay Manager, (2009); 8: 96-97.
6. Wu, L.M., Qiao, H.X., Li, Y.K., Li, L.D.; Cardioprotective effects of the combined use of puerarin and Danshensu on acute ischemic myocardial injury in rats; Phytotherapy Research, (2007); 21: 751-756.
7. Liu, H.B., Xu, J., Peng, Y., Zhou, J.J., Xiao, P.G.; Targets of Danshen's active components for activating blood circulation activities; Acta Physico-Chimica Sinica, (2010); 26: 199-205.
8. Dong, C.N., Wang, Y., Zhu, Y.Z.; Asymmetric synthesis and biological evaluation of Danshensu derivatives as anti-myocardial ischemia drug candidates; Bioorganic and Medicinal Chemistry, (2009); 17: 3499-3507.
9. Cui, Q.B., Chen, Y.H., Zhang, M.J., Shan, L.C., Sun, Y.W., Yu, P., et al.; Design, synthesis and preliminary cardioprotective effect evaluation of Danshensu derivatives; Chemical Biology and Drug Design, (2014); 84(3): 282-291.
10. Wu, L., Qiao, H., Li, Y., Li, L.; Protective roles of puerarin and Danshensu on acute ischemic myocardial injury in rats; Phytomedicine, (2007); 14: 652-658.
11. Lv, L., Jiang, S.S., Gong, J.B., Cheng, Y.; Protective effect of ligustrazine against myocardial ischaemia reperfusion in rats: the role of endothelial nitric oxide synthase; Clinical and Experimental Pharmacology and Physiology, (2012); 39: 20-27.
12. Wang, X.F., Zhao, M.Q.; Ligustrazine and Salvia miltiorrhiza injection solution in complementary therapy of pregnancy-induced hypertension: clinical analysis of 60 cases; Academic Journal of the First Medical College of PLA, (2003); 23: 969-971.
13. Huang, W.D., Yang, Y.F., Chen, J.W., Zhu, B.H.; Synergism of tanshinol and tetramethylpyrazine on cardiovascular system in rats; Chinese Pharmacological Bulletin, (2013); 29: 432-436.
14. Cui, G.Z., Shan, L.C., Hung, M.W., Lei, S.W., Choi, I.L., Zhang, Z.J., et al.; A novel Danshensu derivative confers cardioprotection via PI3K/Akt and Nrf2 pathways; International Journal of Cardiology, (2013); 168: 1349-1359.
15. Zhang, Q.Z., Li, Z.J., Wang, S.X., Nan, Y.F., Zheng, X.H.; Determination of isopropyl 3-(3, 4-dihydroxyphenyl)-2-hydroxypropanoate in plasma and tissue in rabbits by HPLC-MS; Journal of Xi'an Jiaotong University (Medical Sciences), (2009); 30: 635-638.
16. Liu, S.J., Ma, Z.S.; Study on structural characterization, quality control and pharmacokinetic of DBZ. Dissertation. Xibei University, China, 2009.
17. Liu, D., Zheng, X.H., Tang, Y.T.; Metabolism of tanshinol borneol ester in rat and human liver microsomes; Drug Metabolism and Disposition, (2010); 9: 1464-1470.
18. Li, B., Sedlacek, M., Manoharan, I., Boopathy, R., Duysen, E.G., Masson, P., et al.; Butyrylcholinesterase, paraoxonase, and albumin esterase, but not carboxylesterase, are present in human plasma; Biochemical Pharmacology, (2005); 70: 1673-1684.